US Patent

US12564561 — Dilute ready to use large volume containers of phenylephrine

Formulation · Assigned to Sintetica SA · Expires 2044-08-08 · 18y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a ready-to-use, semi-naked dilute solution of phenylephrine that resists oxidative degradation when packaged in certain types of bags.

USPTO Abstract

Ready to use semi-naked dilute solutions of phenylephrine, resistant to oxidative degradation when packaged in transparent or translucent collapsible polypropylene bags and terminally sterilized, without the need for an aluminum over-wrap, oxygen scavengers, oxygen impermeable polypropylene, antioxidants, or chelating agents.

Drugs covered by this patent

phenylephrine-hydrochloride (PHENYLEPHRINE HYDROCHLORIDE)

Patent Metadata

Patent number: US12564561
Jurisdiction: US
Classification: Formulation
Expires: 2044-08-08
Drug substance claim: No
Drug product claim: Yes
Assignee: Sintetica SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.